|
|
|
|
|
Join our live expert webinar
|
|
|
Optimizing Imaging in Metastatic Breast Cancer to Improve Clinical Outcomes
|
|
|
Wednesday, November 17, 2021 • 7:00PM ET
|
|
|
Objectives:
- Review techniques, including radiopharmaceuticals-based imaging techniques, for characterizing estrogen receptor status in metastatic breast cancer
- Discuss best practices for radiopharmaceuticals-based imaging in metastatic breast cancer
- Obtain insights on strategies for identifying the appropriate patients with breast cancer for radiopharmaceuticals-based imaging
- Gain expert perspectives on how the application of radiopharmaceuticals-based imaging can improve clinical outcomes in metastatic breast cancer
|
|
|
|
|
|
|
Gary Ulaner, MD, PhD, FACNM
Diagnostic Radiology, Nuclear Medicine
Hoag Medical Group |
|
|
|
Jeremy Force, DO
Medical Oncologist
Duke Health
|
|
|
|
|
|
|
|
|
